Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.

Michele FusaroliStefano PolizziLuca MenestrinaValentina GiunchiLuca PellegriniEmanuel RaschiDaniel WeintraubMaurizio RecanatiniGastone CastellaniFabrizio De PontiElisabetta Poluzzi

Published in: Drug safety (2024)

The under-explored consequences of drug-induced impulsivity significantly burden patients and families. Network analyses, exploring syndromic reactions and potential precipitating events, complement traditional techniques and clinical judgment. Characterizing the secondary impact of reactions will support informed patient-centered decision making.

Keyphrases

drug induced
liver injury
adverse drug
end stage renal disease
decision making
newly diagnosed
chronic kidney disease
ejection fraction
obsessive compulsive disorder
risk factors
intellectual disability
patient reported outcomes